Clinical Trial Detail

NCT ID NCT03092934
Title A Study of AK-01 in Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors AurKa Pharma Inc.
Indications

lung small cell carcinoma

Her2-receptor negative breast cancer

Advanced Solid Tumor

Therapies

AK-01

Age Groups: adult senior

Additional content available in CKB BOOST